Latest News - McKesson
Top Corporates Hub
McKesson
Monday's session: gap up and gap down stock in the S&P500 index
06.04.2026 14:35
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
The Oncology Institute Names Minh Merchant Chief Legal Officer
06.04.2026 13:00
CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its missio
Is Medline Inc. (MDLN) A Good Stock To Buy Now?
06.04.2026 12:53
Is MDLN a good stock to buy? We came across a bullish thesis on Medline Inc. on The Pursuit of Compounding’s Substack. In this article, we will summarize the bulls’ thesis on MDLN. Medline Inc.’s share was trading at $41.36 as of March 27th. MDLN’s trailing and forward P/E were 29.91 and 29.24 respectively according to Yahoo Finance. Medline Industries (MDLN) […]
B of A Securities Maintains Buy on McKesson, Lowers Price Target to $1000
06.04.2026 09:50
B of A Securities analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Buy and lowers the price target from $1040 to $1000.
Should Upgraded EPS Forecasts and Revenue Momentum Require Action From McKesson (MCK) Investors?
03.04.2026 14:05
In recent days, analysts have raised earnings estimates for McKesson, highlighting its consistent outperformance versus consensus EPS expectations and pointing to continued revenue expansion in pharmaceutical distribution. This wave of positive revisions underscores how McKesson’s execution in its core distribution business is influencing perceptions of its longer-term earnings power. We’ll now examine how these upgraded earnings expectations and McKesson’s consistent EPS outperformance...
Here's Why We Think McKesson (NYSE:MCK) Is Well Worth Watching
03.04.2026 14:00
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
MedMira Reports Second Quarter Results FY2025
02.04.2026 02:00
HALIFAX, NS / ACCESS Newswire / April 1, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026. Corporate update In Q2 FY2026, the Company signed a distribution agreement with McKesson, ...
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
01.04.2026 13:00
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Value-Based Care Payment Market to Grow by $1.5 Billion During 2026-2030, Driven by Expansion of Reimbursement Mandates - McKesson, Change Healthcare, and Premier Lead
01.04.2026 10:46
Value Based Care Payment Market Value Based Care Payment Market Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Value Based Care Payment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global value-based care payment market is poised for significant expansion, driven by a shift from traditional fee-for-service models to more quality-focused care strategies. The market is estimated to increase from $3.17 billion in 2025 to $3.49 billion in 2026, maintaining a compound
How The McKesson (MCK) Narrative Is Shifting With Biosimilars Execution And Richer Valuation
28.03.2026 08:06
McKesson's fair value estimate has shifted only slightly, moving from about US$995.27 to about US$997.67 per share, while recent Street price targets cluster higher in the US$1,040 to US$1,050 range. Analysts are linking those upper tier targets to execution around biosimilars, co-manufacturing, and specialty distribution, while also pointing out where expectations could be getting full. As you read on, you will see how these moving pieces fit together and what to watch as the McKesson story...
McKesson Taps AI Personalization To Support Loyalty And Long Term Growth
28.03.2026 06:04
McKesson (NYSE:MCK) is adopting Exchange Solutions' loyalty and personalization platform as it updates its customer engagement approach. The move is designed to use AI driven decisioning and real time personalization while keeping McKesson's core systems intact. This modernization is aimed at supporting enterprise clients with faster program changes and more tailored interactions. For investors watching NYSE:MCK at a share price of $860.16, this technology shift sits alongside a long...
Saputo Inc. Appoints Linda Mantia to Board of Directors
26.03.2026 15:06
MONTRÉAL, March 26, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) announced today that Linda Mantia has been appointed to its Board of Directors as an independent director. Ms. Mantia is a corporate director and former senior executive with experience in operations, technology, and enterprise transformation across global organizations. She currently serves on the boards of Maple Leaf Foods and Liberty Mutual Corporation, and previously served on the boards of McKess
Exchange Solutions Joins MACH Alliance as Enterprises Shift to Composable, AI-Ready Loyalty Platforms
26.03.2026 12:00
BOSTON, March 26, 2026--Exchange Solutions joins MACH Alliance as enterprises adopt modular, AI-ready loyalty platforms for real-time personalization without costly rebuilds.
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack
25.03.2026 08:13
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including McKesson (NYSE:MCK) and its peers.
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
24.03.2026 14:16
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
Here's Why You Should Add McKesson Stock to Your Portfolio Now
20.03.2026 11:54
McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.
McCormick Confirms Discussions With Unilever On Potential Strategic Transaction Involving Unilever's Foods Business; No Certainty Of Agreement
20.03.2026 03:20
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies
18.03.2026 14:23
GE, SHEL and MCK lead Zacks picks, driven by strong demand, cash flow growth and strategic expansion despite cost and market risks.
McKesson Corp (NYSE:MCK) Presents a Compelling Growth at a Reasonable Price (GARP) Case
18.03.2026 13:31
McKesson Corp (MCK) presents a GARP investment case with solid earnings growth, fair valuation, and strong profitability metrics in the healthcare sector.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
18.03.2026 13:00
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.